Press Releases from Sobera Capital GmbH (3 total)
Sobera Capital’s portfolio company ACT Biotech sells oncology assets to Edding …
Berlin, February 19, 2014 - Sobera Capital’s portfolio company ACT Biotech, San Francisco, CA, sold its worldwide rights to three small molecule drug assets and other molecules to Chinese specialty pharmaceutical company Eddingpharm. The total consideration, including the upfront payment, can reach up to $95 million. Sobera Capital had acquired shares in ACT Biotech in February 2012 in course of a secondary direct transaction from Bayer AG.
Sobera Capital is a…
Sobera Capital exits from cv cryptovision
Berlin, June 20, 2013 – The funds IMH Hannover Venture Capital, IMH Venture Capital Berlin and ACAM Holding, which are managed by Sobera Capital, sold their shares in security software company cv cryptovision GmbH. Acquirer was Bundesdruckerei GmbH which made a strategic investment into cryptovision and now holds 25% in the company.
The funds managed by Sobera Capital had been invested in cryptovision since 2001.
Sobera Capital is a Berlin based independent…
Sobera Capital exits 4Care AG
Berlin, August 28, 2012 – Sobera Capital exits from its portfolio company 4Care AG through a sale of the shares held by the funds Berlin Capital Fund („BCF“) and TCF II in course of a management buy-out.
BCF und TCF II had acquired 4Care AG (formerly Lenscare AG) in 2007 in a secondary transaction from Landesbank Berlin as well as from a co-shareholder. The company which owns brands like Lenscare,…
